#NewMember | "A leading organization in terms of innovation which promotes collaboration a... 22/02/2023 Healthcare Agrifood Industrial biotechnology Corporate Meet CEISA, our new member. We talked to Josep Tascón, CEO of the company. Partners
Cash, cash equivalents and marketable securities totaled $22.7 million as of December 31, ... 20/02/2023 Corporate Strong clinical progress in both oncology and CNS Partners - Oryzon Genomics
Telum Therapeutics names Vincent A. Fischetti chairman of its Scientific Advisory Board 15/02/2023 Corporate Professor Vincent A. Fischetti is the inventor of phage lysins as a new therapeutic and an alternative to conventional... Partners - TELUM THERAPEUTICS
Asabys announces the first close of its fund, with commitments of €100M, and appoints Sylv... 15/02/2023 Financing Corporate Banco Sabadell stands as the firm’s main private institutional investor, like in its previous fund in 2018. Other... Partners - Asabys Partners
aptaTargets’ ApTOLL reduces mortality from 18% to 5% in a Phase 1b/2a trial in ischemic st... 09/02/2023 Healthcare Corporate ApTOLL is the first TLR4 antagonist neuroprotectant to achieve positive efficacy endpoints in acute ischemic stroke... Partners - AptaTargets
BCN HEALTH publishes a study assessing the incidence, mortality and hospital costs of isch... 30/01/2023 Healthcare Corporate BCN HEALTH ha publicado el estudio 'Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs... Partners - BCN Health
GENESIS Biomed sponsors ITEMAS 2022 Annual Conference Day 19/01/2023 Corporate The “Instituto de Investigación Biomédica de Córdoba” hosts the event, supported by “Instituto de Salud Carlos III... Partners - GENESIS Biomed
AptaTargets awarded €2.5 million grant from Spanish government to evaluate ApTOLL for acut... 23/01/2023 Healthcare Access to innovation Corporate The funds are from a competitive call through the 2021 State Programme to Promote Scientific-Technical Research and its... Partners - AptaTargets
Cellab CDMO, Cellab's new activity 19/01/2023 Corporate The Andorran biotech company is working to obtain Good Manufacturing Practices (GMP) during the first half of 2023 Partners - Cellab
Ysios Capital strengthens its team with internal promotions and a new Venture Partner 19/01/2023 Access to innovation Corporate Jordi Xiol has been promoted to Partner after joining Ysios Capital in 2019 Ysios is also incorporating Sanifit co... Partners - Ysios Capital Partners
